Enhancer remodeling drives MLL oncogene-dependent transcriptional dysregulation in leukemia stem cells

Tsai, 2017, Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development, Oncogene, 36, 1753, 10.1038/onc.2016.315 Krivtsov, 2007, MLL translocations, histone modifications and leukaemia stem-cell development, Nat Rev Cancer, 7, 823, 10.1038/nrc2253 Liedtke, 2009, Therapeutic targeting of MLL, Blood, 113, 6061, 10.1182/blood-2008-12-197061 Krivtsov, 2008, H3K79 methylation profiles define murine and human MLL-AF4 leukemias, Cancer Cell, 14, 355, 10.1016/j.ccr.2008.10.001 Somervaille, 2009, Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells, Cell Stem Cell, 4, 129, 10.1016/j.stem.2008.11.015 Meyer, 2018, The MLL recombinome of acute leukemias in 2017, Leukemia, 32, 273, 10.1038/leu.2017.213 Iwasaki, 2015, CD93 marks a non-quiescent human leukemia stem cell population and is required for development of MLL-rearranged acute myeloid leukemia, Cell Stem Cell, 17, 412, 10.1016/j.stem.2015.08.008 Somervaille, 2006, Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia, Cancer Cell, 10, 257, 10.1016/j.ccr.2006.08.020 Krivtsov, 2006, Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9, Nature, 442, 818, 10.1038/nature04980 Long, 2016, Ever-changing landscapes: transcriptional enhancers in development and evolution, Cell, 167, 1170, 10.1016/j.cell.2016.09.018 Sur, 2016, The role of enhancers in cancer, Nat Rev Cancer, 16, 483, 10.1038/nrc.2016.62 Calo, 2013, Modification of enhancer chromatin: what, how, and why?, Mol Cell, 49, 825, 10.1016/j.molcel.2013.01.038 Yang, 2016, DNMT3A loss drives enhancer hypomethylation in FLT3-ITD-associated leukemias, Cancer Cell, 30, 363, 10.1016/j.ccell.2016.07.015 Bahr, 2018, A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies, Nature, 553, 515, 10.1038/nature25193 McKeown, 2017, Superenhancer analysis defines novel epigenomic subtypes of non-APL AML, including an RARalpha dependency targetable by SY-1425, a potent and selective RARalpha agonist, Cancer Discov, 7, 1136, 10.1158/2159-8290.CD-17-0399 Wong, 2015, The H3K4-methyl epigenome regulates leukemia stem cell oncogenic potential, Cancer Cell, 28, 198, 10.1016/j.ccell.2015.06.003 Jeong, 2019, High-efficiency CRISPR induction of t(9;11) chromosomal translocations and acute leukemias in human blood stem cells, Blood Adv, 3, 2825, 10.1182/bloodadvances.2019000450 Lara-Astiaso, 2014, Immunogenetics. Chromatin state dynamics during blood formation, Science, 345, 943, 10.1126/science.1256271 Li, 2009, Fast and accurate short read alignment with Burrows–Wheeler transform, bioinformatics, 25, 1754, 10.1093/bioinformatics/btp324 Zhang, 2008, Model-based analysis of ChIP-Seq (MACS), Genome biology, 9, 1, 10.1186/gb-2008-9-9-r137 Ernst, 2012, ChromHMM: automating chromatin-state discovery and characterization, Nat Methods, 9, 215, 10.1038/nmeth.1906 McLean, 2010, GREAT improves functional interpretation of cis-regulatory regions, Nat Biotechnol, 28, 495, 10.1038/nbt.1630 Ramirez, 2016, deepTools2: a next generation web server for deep-sequencing data analysis, Nucleic Acids Res, 44, W160, 10.1093/nar/gkw257 Shen, 2014, ngs.plot: quick mining and visualization of next-generation sequencing data by integrating genomic databases, BMC Genomics, 15, 284, 10.1186/1471-2164-15-284 Whyte, 2013, Master transcription factors and mediator establish super-enhancers at key cell identity genes, Cell, 153, 307, 10.1016/j.cell.2013.03.035 Heinz, 2010, Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities, Mol Cell, 38, 576, 10.1016/j.molcel.2010.05.004 Szklarczyk, 2019, STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets, Nucleic acids research, 47, D607, 10.1093/nar/gky1131 Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinformatics, 29, 15, 10.1093/bioinformatics/bts635 Ge, 2018, iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data, BMC Bioinformatics, 19, 534, 10.1186/s12859-018-2486-6 Love, 2014, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol, 15, 550, 10.1186/s13059-014-0550-8 Wang, 2017, WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit, Nucleic Acids Res, 45, W130, 10.1093/nar/gkx356 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci U S A, 102, 15545, 10.1073/pnas.0506580102 Prange, 2017, MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia, Oncogene, 36, 3346, 10.1038/onc.2016.488 Sun, 2018, HOXA9 reprograms the enhancer landscape to promote leukemogenesis, Cancer Cell, 34, 643, 10.1016/j.ccell.2018.08.018 Local, 2018, Identification of H3K4me1-associated proteins at mammalian enhancers, Nat Genet, 50, 73, 10.1038/s41588-017-0015-6 Dorighi, 2017, Mll3 and Mll4 facilitate enhancer RNA synthesis and transcription from promoters independently of H3K4 monomethylation, Mol Cell, 66, 568, 10.1016/j.molcel.2017.04.018 Sondka, 2018, The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers, Nat Rev Cancer, 18, 696, 10.1038/s41568-018-0060-1 Liu, 2017, ONGene: A literature-based database for human oncogenes, J Genet Genomics, 44, 119, 10.1016/j.jgg.2016.12.004 Pinto, 2015, StemChecker: a web-based tool to discover and explore stemness signatures in gene sets, Nucleic Acids Res, 43, W72, 10.1093/nar/gkv529 Medvedeva, 2015, EpiFactors: a comprehensive database of human epigenetic factors and complexes, Database (Oxford), 2015, bav067, 10.1093/database/bav067 Han, 2018, TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions, Nucleic Acids Res, 46, D380, 10.1093/nar/gkx1013 Bagger, 2019, BloodSpot: a database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles, Nucleic Acids Res, 47, D881, 10.1093/nar/gky1076 Jin, 2011, Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation, EMBO J, 30, 249, 10.1038/emboj.2010.318 Tang, 2017, GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses, Nucleic Acids Res, 45, W98, 10.1093/nar/gkx247 Meyers, 2017, Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells, Nat Genet, 49, 1779, 10.1038/ng.3984 Lasko, 2017, Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours, Nature, 550, 128, 10.1038/nature24028 Bhagwat, 2018, Enhancer dysfunction in leukemia, Blood, 131, 1795, 10.1182/blood-2017-11-737379 Cao, 2018, An Mll4/COMPASS-Lsd1 epigenetic axis governs enhancer function and pluripotency transition in embryonic stem cells, Sci Adv, 4, eaap8747, 10.1126/sciadv.aap8747 Mumbach, 2017, Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements, Nat Genet, 49, 1602, 10.1038/ng.3963 Wang, 2022, CBP/p300 and HDAC activities regulate H3K27 acetylation dynamics and zygotic genome activation in mouse preimplantation embryos, EMBO J, 41, e112012, 10.15252/embj.2022112012 Gregoricchio, 2022, HDAC1 and PRC2 mediate combinatorial control in SPI1/PU.1-dependent gene repression in murine erythroleukaemia, Nucleic Acids Res, 50, 7938, 10.1093/nar/gkac613 Picaud, 2015, Generation of a selective small molecule inhibitor of the CBP/p300 bromodomain for leukemia therapy, Cancer Res, 75, 5106, 10.1158/0008-5472.CAN-15-0236 Diesch, 2021, Inhibition of CBP synergizes with the RNA-dependent mechanisms of azacitidine by limiting protein synthesis, Nat Commun, 12, 6060, 10.1038/s41467-021-26258-z Daigle, 2011, Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor, Cancer Cell, 20, 53, 10.1016/j.ccr.2011.06.009 Yokoyama, 2005, The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis, Cell, 123, 207, 10.1016/j.cell.2005.09.025 Ishikawa, 2007, Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region, Nat Biotechnol, 25, 1315, 10.1038/nbt1350 Pollyea, 2014, Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials, Haematologica, 99, 1277, 10.3324/haematol.2013.085209